e-learning
resources
Barcelona 2013
Wednesday, 11.09.2013
Growth factors at the crossroads of acute and chronic inflammation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LSC 2013 abstract - Mechanisms regulating enhanced alphavbeta6 expression in pulmonary fibrosis
A. Tatler, A. Goodwin, O. Gbolohan, R. Clifford, P. Weinreb, S. Violette, M. Kolb, J. Gauldie, P. Wolters, A. Knox, G. Jenkins (Nottingham, United Kingdom; Cambridge, San Francisco, United States Of America; Hamilton, Canada)
Source:
Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Session:
Growth factors at the crossroads of acute and chronic inflammation
Session type:
Poster Discussion
Number:
4884
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Tatler, A. Goodwin, O. Gbolohan, R. Clifford, P. Weinreb, S. Violette, M. Kolb, J. Gauldie, P. Wolters, A. Knox, G. Jenkins (Nottingham, United Kingdom; Cambridge, San Francisco, United States Of America; Hamilton, Canada). LSC 2013 abstract - Mechanisms regulating enhanced alphavbeta6 expression in pulmonary fibrosis. Eur Respir J 2013; 42: Suppl. 57, 4884
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
LSC 2013 abstract - Unravelling VEGF165 signalling in the lung
Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Year: 2013
Regulation of alternative macrophage activation by galectin-3; potential role in lung fibrosis
Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Year: 2009
Dual role of pulmonary T cells in fibrosis is defined by expression of integrins
Source: Annual Congress 2009 - Mechanisms of pulmonary inflammation and fibrosis
Year: 2009
LSC 2013 abstract - Abnormal neutrophil migration is a feature of early COPD, present across disease phenotypes and causally related to increased phosphoinositide-3-kinase signalling
Source: Annual Congress 2013 –Molecular biology: state-of-the-art 2013
Year: 2013
LSC 2012 abstract – Activation of Wnt/β-catenin signaling promotes lung epithelial repair in emphysema
Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation
Year: 2012
LSC 2013 abstract - Activin-A is up-regulated in severe asthma and is associated with angiogenesis
Source: Annual Congress 2013 –Asthma: new mechanisms and markers
Year: 2013
LSC 2010 Abstract: Protease-activated receptor-2 plays a pivotal role in pulmonary fibrosis by inducing myofibroblast differentiation and tissue factor up-regulation
Source: Annual Congress 2010 - Stem cells and growth factors in lung injury
Year: 2010
rHuKGF optimistically attenuates MAPK/ERK mediated cell proliferation pathway in emphysematous lungs
Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases
Year: 2013
K
Ca
3.1 mediates alphaSMA expression in human lung myofibroblast via the Smad2/3 and TGFbeta1 signalling pathway
Source: International Congress 2014 – Cell biology 2014
Year: 2014
A role for WNT-5B in airway remodeling in COPD by activation of TGF-beta/Smad3 signaling?
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
c-Met expression induction in immune cells modulates pulmonary fibrosis progression
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020
RhoA signalling influences cyclin D1 expression and associated fibroblast turnover: implications for idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2006 - Lung vascular and parenchymal remodeling
Year: 2006
Late Breaking Abstract - B cells are not involved in the regulation of adenoviral TGF-ß1- or bleomycin-induced lung fibrosis in mice
Source: Virtual Congress 2021 – Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseases
Year: 2021
Elevated integrin ?5 expression in idiopathic pulmonary fibrosis (IPF) derived fibroblasts is linked to paracrine TNF-a signaling
Source: International Congress 2017 – Cellular signalling pathways in pulmonary fibrosis
Year: 2017
Young Investigator session: Mechanisms regulating enhanced ?v?6 expression in pulmonary fibrosis
Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease
Year: 2013
Toll like receptor 4 activation upregulates miR-181b attenuating pulmonary fibrosis via targeting TGFBR1
Source: International Congress 2015 – Latest news on miRNAs in pulmonary research
Year: 2015
LSC 2013 abstract - Bioavailability of VEGF in idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Year: 2013
Alterations in gene expression of RAGE and its sheddases in blood of COPD patients do not relate to decreased plasma (e)sRAGE levels
Source: International Congress 2014 – Mechanisms of COPD and inhalation injury
Year: 2014
WNT-4 regulates pro-inflammatory responses driven by epithelial-mesenchymal cross-talk
Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action
Year: 2016
The role of chemokine receptors in the aberrant migration of COPD neutrophils
Source: International Congress 2014 – Cell biology 2014
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept